AXSM/ 12/31/2025 · 7:12 AM FDA Fast-Tracks Review of New Alzheimer's Agitation Treatment Axsome's AXS-05 gets FDA priority review for treating agitation in Alzheimer's patients, with decision expected by April 2026.
